Leadership

Dr. Manasco’s clinical research experience spans more than 25 years. It includes stints at the National Institutes of Health and then roles of increasing responsibility at Burroughs Wellcome, GlaxoWellcome, GlaxoSmithKline, and two clinical research software companies.

Dr. Manasco developed the MANA Method for Quality, Risk-Based Trial Management including Risk-Based Monitoring by using the experience and expertise she gained while working as an Investigator, Medical Monitor, Clinical Program Leader, and Pharmaceutical Executive (Vice President) and two technology start-ups in clinical research.

Her career focus and passion fuels the MANA Mission of helping Pharma and Biotech Companies, Device Companies, and Clinical and Academic Research Organizations (CRO, ARO), implement technology and processes to enhance quality, efficiency, and patient safety in clinical research.